Jump to content

Driving the Development
of RNA Therapeutics

Accelerate the design and development of RNA therapeutics and vaccines end-to-end with Genedata Biologics®. Optimize RNA/DNA for effectiveness and stability, and develop delivery systems that ensure durability and reliable target tissue delivery.

Vaccine Discovery

Novel mRNA Vaccines

Genedata Biologics scalable and customizable data architecture enables the registration, testing and evaluation of nucleic acid-based therapeutics and vaccines at every stage of development. End-to-end capture of data relating to design, production, testing, and quality control increases the efficiency and throughput. Genedata Biologics facilitates registration of modified nucleosides and the automatic computation of associated physicochemical properties. In addition, delivery system information is captured and tracked, e.g., lipid composition in LNPs. Combined with powerful screening workflow tools for formulation development and functional characterization, the platform delivers critical data infrastructure to realize the promise of RNA therapeutics.

Learn More

Want to Speed Up Discovery of RNA-Based Therapies?

Contact an Expert